Company performance
Add to research
Current Price
as of May 20, 2025$2.34
P/E Ratio
N/A
Market Cap
$23.96M
Description
Add to research
NexGel, Inc. engages in the manufacture of aqueous polymer hydrogels used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. It operates through the NexGel and CGN segments. The NexGel segment consists of the manufacturing of ultra-gentle, high-water-content hydrogel products for healthcare and consumer applications, which is based in Langhorne, Pennsylvania. The CGN segment consists of the CGN JV used for the company’s converting and packaging business, which is based in Granbury, Texas. The company was founded on January 13, 2009, and is headquartered in Langhorne, PA.
Metrics
Add to research
Overview
- HQLanghorne, PA
- SectorProcess Industries
- IndustryChemicals: Specialty
- TickerNXGL
- Price$2.34-2.09%
Trading Information
- Market cap$23.96M
- Float80.25%
- Average Daily Volume (1m)39,793
- Average Daily Volume (3m)45,738
- EPS-$0.46
Company
- Revenue$10.23M
- Rev growth (1yr)121.64%
- Net income-$0.71M
- Gross margin40.84%
- EBITDA margin-23.20%
- EBITDA-$0.65M
- EV$24.69M
- EV/Revenue2.41
- P/EN/A
- P/S1.75
- P/B3.44
- Debt/Equity52.64
Documents
Add to research
SEC Filings
Earnings Calls